文献速递疼痛医学

微型植入式脉冲发生器治疗周围神经病理性疼痛的随机对照试验

Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain: 3-month and 6-month results from the COMFORT-randomised controlled trial.
PubMed 文献 · Reg Anesth Pain Med · 2025-07-04

COMFORT随机对照试验评估微型植入式脉冲发生器用于周围神经刺激治疗慢性周围疼痛,受试者按2:1随机分配至活性组(PNS联合常规药物治疗)或对照组(仅常规药物治疗)。3个月主要终点时活性组应答率84%、平均疼痛减轻67%,对照组分别为3%和6%(p<0.001);6个月时活性组应答率88%、平均疼痛减轻70%,未报告囊袋疼痛和严重器械不良事件。

要点

  • 3个月主要终点活性组应答率84%显著优于对照组3%(p<0.001)。
  • 6个月活性组应答率88%、平均疼痛减轻70%。
  • 未报告囊袋疼痛和严重器械不良事件,81%受试者认为外部穿戴组件舒适。

核心结论

  • 该研究达到主要终点,3个月时活性组应答率显著优于对照组。
  • 结果表明该微型植入式脉冲发生器行周围神经刺激有效且安全。

研究设计与样本

  • 首次大型上市后多中心随机对照试验,评估微型植入式脉冲发生器行周围神经刺激治疗慢性周围疼痛。
  • 受试者按2:1随机分配至活性组(PNS联合常规药物治疗)或对照组(仅常规药物治疗)。
  • 治疗部位限于下背部、肩部、膝部和足/踝。

主要发现

  • 3个月主要终点时活性组应答率84%、平均疼痛减轻67%,对照组应答率3%、平均疼痛减轻6%(p<0.001)。
  • 6个月时活性组应答率88%、平均疼痛减轻70%。
  • 多数患者报告结局也达到统计学显著性。
  • 未报告囊袋疼痛和严重器械不良事件。
  • 81%受试者认为PNS系统的外部穿戴组件舒适。

临床怎么用

  • 对于下背部、肩部、膝部和足/踝的慢性周围疼痛,可考虑使用该微型植入式脉冲发生器行周围神经刺激联合常规药物治疗。

局限性

  • 研究正在进行中,计划随访受试者3年,长期结果尚待报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We report the results from the first large, postmarket, multicentre, randomised controlled trial (RCT) evaluating peripheral nerve stimulation (PNS) for the treatment of chronic peripheral pain with a micro-implantable pulse generator (micro-IPG). METHODS: Subjects meeting eligibility were randomised (2:1) to either the active arm receiving PNS and conventional medical management (CMM) or the control arm receiving CMM alone. Treatments were limited to the following areas: lower back, shoulder, knee and foot/ankle. RESULTS: At 6 months, the active arm achieved an 88% responder rate with a 70% average reduction in pain. At the 3-month primary endpoint, the active arm achieved an 84% responder rate with an average pain reduction of 67% compared with the control arm, which achieved a 3% responder rate with an average pain reduction of 6%. Both responder rate and pain reduction in the active arm were significantly better than in the control arm (p<0.001). A majority of patient-reported outcomes also reached statistical significance. There have been no reports of pocket pain and no serious adverse device effects. 81% of subjects found the external wearable component of the PNS system to be comfortable. CONCLUSIONS: This study successfully reached its primary endpoint-the active arm achieved a statistically significant superior responder rate as compared with the control arm at 3 months. These RCT results demonstrated that PNS, with this micro-IPG, is efficacious and safe. This ongoing study will follow subjects for 3 years, the results of which will be reported as they become available.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Hatheway J, Hersel A, Song J, et al. Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain: 3-month and 6-month results from the COMFORT-randomised controlled trial. Reg Anesth Pain Med. 2025. PMID: 38821535. doi:10.1136/rapm-2023-105264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。